(-)-epigallocatechin 3-gallate decreases expression ISO ANXA4 (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of ANXA4 protein CTD PMID:31195006 (1->4)-beta-D-glucan multiple interactions ISO Anxa4 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA4 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Anxa4 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANXA4 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Anxa4 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ANXA4 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ANXA4 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO Anxa4 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of ANXA4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ANXA4 mRNA CTD PMID:17557909 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ANXA4 protein CTD PMID:32145629 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO ANXA4 (Homo sapiens) 6480464 Metribolone results in increased expression of ANXA4 protein CTD PMID:17152098 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO Anxa4 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA4 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANXA4 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Anxa4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANXA4 mRNA CTD PMID:23994337 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Anxa4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA4 mRNA CTD PMID:18343893 and PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO ANXA4 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA4 mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Anxa4 (Mus musculus) 6480464 2 more ... CTD PMID:18343893 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of ANXA4 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of ANXA4 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Anxa4 (Mus musculus) 6480464 3 more ... CTD PMID:23994337 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ANXA4 protein CTD PMID:34915118 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of ANXA4 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ANXA4 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO Anxa4 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ANXA4 mRNA CTD PMID:18648102 5-aza-2'-deoxycytidine multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [Decitabine co-treated with Vorinostat] affects the expression of ANXA4 mRNA CTD PMID:17330099 5-fluorouracil decreases expression ISO ANXA4 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of ANXA4 mRNA CTD PMID:15109396 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of ANXA4 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of ANXA4 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO Anxa4 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of ANXA4 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO ANXA4 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of ANXA4 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO ANXA4 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of ANXA4 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO ANXA4 (Homo sapiens) 6480464 Tretinoin results in increased expression of ANXA4 mRNA CTD PMID:21934132 and PMID:33167477 amiodarone increases expression ISO ANXA4 (Homo sapiens) 6480464 Amiodarone results in increased expression of ANXA4 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANXA4 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ANXA4 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO ANXA4 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ANXA4 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Anxa4 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ANXA4 mRNA CTD PMID:23650126 arsane affects methylation ISO ANXA4 (Homo sapiens) 6480464 Arsenic affects the methylation of ANXA4 gene CTD PMID:25304211 arsenic atom affects methylation ISO ANXA4 (Homo sapiens) 6480464 Arsenic affects the methylation of ANXA4 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO ANXA4 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to ANXA4 mRNA] CTD PMID:32406909 belinostat decreases expression ISO ANXA4 (Homo sapiens) 6480464 belinostat results in decreased expression of ANXA4 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO Anxa4 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ANXA4 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO ANXA4 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of ANXA4 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO Anxa4 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ANXA4 mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO Anxa4 (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to ANXA4 promoter] CTD PMID:19654925 benzo[e]pyrene decreases methylation ISO ANXA4 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of ANXA4 intron CTD PMID:30157460 benzoates decreases expression ISO ANXA4 (Homo sapiens) 6480464 Benzoates analog results in decreased expression of ANXA4 mRNA CTD PMID:29472718 beta-naphthoflavone decreases expression ISO Anxa4 (Mus musculus) 6480464 beta-Naphthoflavone results in decreased expression of ANXA4 mRNA CTD PMID:23994337 bis(2-ethylhexyl) phthalate decreases expression ISO ANXA4 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of ANXA4 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO ANXA4 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of ANXA4 mRNA CTD PMID:31163220 bisphenol A increases expression ISO ANXA4 (Homo sapiens) 6480464 bisphenol A results in increased expression of ANXA4 mRNA and bisphenol A results in increased expression of ANXA4 protein CTD PMID:25047013 and PMID:37567409 bisphenol A decreases expression ISO ANXA4 (Homo sapiens) 6480464 bisphenol A results in decreased expression of ANXA4 protein CTD PMID:34186270 bisphenol A increases expression ISO Anxa4 (Mus musculus) 6480464 bisphenol A results in increased expression of ANXA4 mRNA CTD PMID:34585602 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ANXA4 protein CTD PMID:32145629 bisphenol A affects expression ISO ANXA4 (Homo sapiens) 6480464 bisphenol A affects the expression of ANXA4 mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANXA4 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO ANXA4 (Homo sapiens) 6480464 bisphenol B results in increased expression of ANXA4 protein CTD PMID:34186270 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of ANXA4 protein CTD PMID:25933445 butanal decreases expression ISO ANXA4 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of ANXA4 mRNA CTD PMID:26079696 butyric acid decreases expression ISO ANXA4 (Homo sapiens) 6480464 Butyric Acid results in decreased expression of ANXA4 protein CTD PMID:34581912 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ANXA4 mRNA CTD PMID:33453195 caffeine decreases expression ISO ANXA4 (Homo sapiens) 6480464 Caffeine results in decreased expression of ANXA4 protein CTD PMID:31195006 caffeine affects phosphorylation ISO ANXA4 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of ANXA4 protein CTD PMID:35688186 camptothecin increases expression ISO ANXA4 (Homo sapiens) 6480464 Camptothecin results in increased expression of ANXA4 mRNA CTD PMID:17374387 carbamazepine affects expression ISO ANXA4 (Homo sapiens) 6480464 Carbamazepine affects the expression of ANXA4 mRNA CTD PMID:25979313 carboplatin decreases response to substance ISO ANXA4 (Homo sapiens) 6480464 ANXA4 protein results in decreased susceptibility to Carboplatin CTD PMID:24150977 carboplatin affects localization ISO ANXA4 (Homo sapiens) 6480464 Carboplatin affects the localization of ANXA4 protein CTD PMID:24150977 carboplatin multiple interactions ISO ANXA4 (Homo sapiens) 6480464 ATP7A protein promotes the reaction [ANXA4 protein results in decreased susceptibility to Carboplatin] CTD PMID:24150977 chlorpyrifos increases expression ISO Anxa4 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ANXA4 mRNA CTD PMID:37019170 choline multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ANXA4 protein CTD PMID:19566968 cisplatin multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ANXA4 mRNA and ATP7A protein promotes the reaction [ANXA4 protein results in decreased susceptibility to Cisplatin] CTD PMID:24150977 and PMID:27392435 cisplatin increases expression ISO ANXA4 (Homo sapiens) 6480464 Cisplatin results in increased expression of ANXA4 mRNA CTD PMID:27392435 cisplatin affects localization ISO ANXA4 (Homo sapiens) 6480464 Cisplatin affects the localization of ANXA4 protein CTD PMID:24150977 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ANXA4 mRNA CTD PMID:24386269 copper atom affects binding ISO ANXA4 (Homo sapiens) 6480464 ANXA4 protein binds to Copper CTD PMID:14534351 and PMID:15359738 copper(0) affects binding ISO ANXA4 (Homo sapiens) 6480464 ANXA4 protein binds to Copper CTD PMID:14534351 and PMID:15359738 copper(II) sulfate decreases expression ISO ANXA4 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of ANXA4 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO ANXA4 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ANXA4 mRNA CTD PMID:25562108 and PMID:27989131 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of ANXA4 mRNA CTD PMID:19575532 D-penicillamine decreases expression EXP 6480464 Penicillamine results in decreased expression of ANXA4 mRNA CTD PMID:19575532 daunorubicin increases expression ISO ANXA4 (Homo sapiens) 6480464 Daunorubicin results in increased expression of ANXA4 mRNA CTD PMID:17374387 dexamethasone increases expression ISO Anxa4 (Mus musculus) 6480464 Dexamethasone results in increased expression of ANXA4 mRNA CTD PMID:22733784 dexamethasone increases expression ISO ANXA4 (Homo sapiens) 6480464 Dexamethasone results in increased expression of ANXA4 mRNA CTD PMID:25047013 dextran sulfate multiple interactions ISO Anxa4 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANXA4 mRNA CTD PMID:29950665 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of ANXA4 mRNA CTD PMID:18636392 dicrotophos decreases expression ISO ANXA4 (Homo sapiens) 6480464 dicrotophos results in decreased expression of ANXA4 mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ANXA4 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO ANXA4 (Homo sapiens) 6480464 Doxorubicin results in increased expression of ANXA4 mRNA CTD PMID:29803840 entinostat multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA4 mRNA CTD PMID:27188386 entinostat increases expression ISO ANXA4 (Homo sapiens) 6480464 entinostat results in increased expression of ANXA4 mRNA CTD PMID:26272509 enzalutamide affects expression ISO ANXA4 (Homo sapiens) 6480464 enzalutamide affects the expression of ANXA4 mRNA CTD PMID:30940724 ethanol increases expression ISO Anxa4 (Mus musculus) 6480464 Ethanol results in increased expression of ANXA4 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO ANXA4 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of ANXA4 mRNA CTD PMID:23649840 etoposide increases expression ISO ANXA4 (Homo sapiens) 6480464 Etoposide results in increased expression of ANXA4 mRNA CTD PMID:17374387 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of ANXA4 mRNA CTD PMID:18035473 fluorescein 5-isothiocyanate affects binding ISO ANXA4 (Homo sapiens) 6480464 Fluorescein-5-isothiocyanate binds to ANXA4 protein CTD PMID:27129696 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ANXA4 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ANXA4 protein CTD PMID:19566968 folic acid multiple interactions ISO Anxa4 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANXA4 mRNA CTD PMID:22206623 formaldehyde increases expression ISO ANXA4 (Homo sapiens) 6480464 Formaldehyde results in increased expression of ANXA4 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of ANXA4 mRNA CTD PMID:26194646 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ANXA4 mRNA CTD PMID:22061828 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ANXA4 mRNA CTD PMID:24136188 glyphosate increases methylation EXP 6480464 Glyphosate results in increased methylation of ANXA4 gene CTD PMID:31011160 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA4 protein] CTD PMID:23178681 hydrogen peroxide affects expression ISO ANXA4 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of ANXA4 mRNA CTD PMID:20044591 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ANXA4 protein CTD PMID:23178681 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA4 protein] CTD PMID:23178681 ivermectin decreases expression ISO ANXA4 (Homo sapiens) 6480464 Ivermectin results in decreased expression of ANXA4 protein CTD PMID:32959892 ketamine increases expression EXP 6480464 Ketamine results in increased expression of ANXA4 mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ANXA4 protein CTD PMID:19566968 lead(0) decreases expression ISO ANXA4 (Homo sapiens) 6480464 Lead results in decreased expression of ANXA4 mRNA CTD PMID:19921347 lipopolysaccharide decreases methylation ISO Anxa4 (Mus musculus) 6480464 Lipopolysaccharides results in decreased methylation of ANXA4 gene CTD PMID:21212295 lipopolysaccharide multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ANXA4 mRNA CTD PMID:26667767 lithium atom increases expression EXP 6480464 Lithium results in increased expression of ANXA4 protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of ANXA4 protein CTD PMID:18296634 lithocholic acid multiple interactions ISO Anxa4 (Mus musculus) 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA4 mRNA] CTD PMID:20359477 lithocholic acid increases expression ISO Anxa4 (Mus musculus) 6480464 Lithocholic Acid results in increased expression of ANXA4 mRNA CTD PMID:20359477 lovastatin decreases expression ISO Anxa4 (Mus musculus) 6480464 Lovastatin results in decreased expression of ANXA4 mRNA CTD PMID:20493250 mercury dibromide increases expression ISO ANXA4 (Homo sapiens) 6480464 mercuric bromide results in increased expression of ANXA4 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA4 mRNA CTD PMID:27188386 methapyrilene decreases methylation ISO ANXA4 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of ANXA4 intron CTD PMID:30157460 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ANXA4 gene CTD PMID:35440735 methyl methanesulfonate increases expression ISO ANXA4 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ANXA4 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO ANXA4 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of ANXA4 mRNA CTD PMID:23179753 methylparaben decreases expression ISO ANXA4 (Homo sapiens) 6480464 methylparaben results in decreased expression of ANXA4 mRNA CTD PMID:31745603 microcystin-LR increases expression ISO Anxa4 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of ANXA4 mRNA CTD PMID:17654400 N-methyl-4-phenylpyridinium increases expression ISO Anxa4 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ANXA4 protein CTD PMID:26558463 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ANXA4 mRNA CTD PMID:25380136 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of ANXA4 protein CTD PMID:19716841 nickel atom decreases expression ISO ANXA4 (Homo sapiens) 6480464 Nickel results in decreased expression of ANXA4 mRNA CTD PMID:23195993 niclosamide increases expression ISO ANXA4 (Homo sapiens) 6480464 Niclosamide results in increased expression of ANXA4 mRNA CTD PMID:36318118 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of ANXA4 mRNA CTD PMID:24136188 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ANXA4 protein CTD PMID:31369848 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ANXA4 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of ANXA4 mRNA CTD PMID:18636392 paclitaxel decreases response to substance ISO ANXA4 (Homo sapiens) 6480464 ANXA4 results in decreased susceptibility to Paclitaxel CTD PMID:21636539 paracetamol affects expression ISO Anxa4 (Mus musculus) 6480464 Acetaminophen affects the expression of ANXA4 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ANXA4 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO Anxa4 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of ANXA4 mRNA] CTD PMID:29246445 paracetamol increases expression ISO Anxa4 (Mus musculus) 6480464 Acetaminophen results in increased expression of ANXA4 mRNA CTD PMID:29246445 paracetamol increases expression ISO ANXA4 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ANXA4 mRNA CTD PMID:22230336 paracetamol decreases expression ISO ANXA4 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ANXA4 mRNA CTD PMID:21420995 and PMID:29067470 perfluorohexanesulfonic acid decreases expression ISO Anxa4 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of ANXA4 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of ANXA4 mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid multiple interactions ISO Anxa4 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA4 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO ANXA4 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of ANXA4 protein CTD PMID:26879310 perfluorooctanoic acid increases expression ISO ANXA4 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of ANXA4 mRNA CTD PMID:36326898 phenobarbital decreases methylation ISO Anxa4 (Mus musculus) 6480464 Phenobarbital results in decreased methylation of ANXA4 gene CTD PMID:19233941 phenylmercury acetate increases expression ISO ANXA4 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of ANXA4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA4 mRNA CTD PMID:27188386 phenytoin increases expression ISO ANXA4 (Homo sapiens) 6480464 Phenytoin results in increased expression of ANXA4 mRNA CTD PMID:14741686 platinum decreases abundance ISO ANXA4 (Homo sapiens) 6480464 ANXA4 protein results in decreased abundance of Platinum CTD PMID:24150977 platinum(0) decreases abundance ISO ANXA4 (Homo sapiens) 6480464 ANXA4 protein results in decreased abundance of Platinum CTD PMID:24150977 pregnenolone 16alpha-carbonitrile multiple interactions ISO Anxa4 (Mus musculus) 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA4 mRNA] CTD PMID:20359477 prostaglandin F2alpha increases expression EXP 6480464 Dinoprost results in increased expression of ANXA4 mRNA CTD PMID:11517196 quercetin increases expression ISO ANXA4 (Homo sapiens) 6480464 Quercetin results in increased expression of ANXA4 protein CTD PMID:14750173 resveratrol multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ANXA4 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of ANXA4 mRNA CTD PMID:23557933 and PMID:26667767 rotenone increases expression ISO ANXA4 (Homo sapiens) 6480464 Rotenone results in increased expression of ANXA4 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO ANXA4 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of ANXA4 mRNA CTD PMID:25895662 silver atom increases expression ISO Anxa4 (Mus musculus) 6480464 Silver results in increased expression of ANXA4 mRNA CTD PMID:27131904 silver(0) increases expression ISO Anxa4 (Mus musculus) 6480464 Silver results in increased expression of ANXA4 mRNA CTD PMID:27131904 Soman increases expression EXP 6480464 Soman results in increased expression of ANXA4 mRNA CTD PMID:19281266 temozolomide decreases expression ISO ANXA4 (Homo sapiens) 6480464 Temozolomide results in decreased expression of ANXA4 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO ANXA4 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of ANXA4 mRNA CTD PMID:15336504 tetrachloromethane increases expression ISO Anxa4 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ANXA4 mRNA CTD PMID:31919559 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of ANXA4 protein CTD PMID:35544339 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ANXA4 mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide multiple interactions ISO Anxa4 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANXA4 mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ANXA4 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ANXA4 mRNA CTD PMID:25729387 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of ANXA4 mRNA CTD PMID:21683754 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ANXA4 mRNA CTD PMID:33387578 trichostatin A increases expression ISO ANXA4 (Homo sapiens) 6480464 trichostatin A results in increased expression of ANXA4 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA4 mRNA CTD PMID:27188386 triptonide decreases expression ISO Anxa4 (Mus musculus) 6480464 triptonide results in decreased expression of ANXA4 mRNA CTD PMID:33045310 tunicamycin increases expression ISO Anxa4 (Mus musculus) 6480464 Tunicamycin results in increased expression of ANXA4 mRNA CTD PMID:17127020 urethane decreases expression ISO ANXA4 (Homo sapiens) 6480464 Urethane results in decreased expression of ANXA4 mRNA CTD PMID:28818685 valproic acid increases expression ISO ANXA4 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ANXA4 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO ANXA4 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ANXA4 mRNA CTD PMID:28001369 and PMID:29154799 valproic acid multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA4 mRNA CTD PMID:27188386 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ANXA4 mRNA CTD PMID:19015723 vorinostat multiple interactions ISO ANXA4 (Homo sapiens) 6480464 [decitabine co-treated with vorinostat] affects the expression of ANXA4 mRNA CTD PMID:17330099 warfarin decreases expression ISO Anxa4 (Mus musculus) 6480464 Warfarin results in decreased expression of ANXA4 mRNA CTD PMID:20493250